PharmaResearch Co., Ltd. (KOSDAQ:214450)
South Korea · Delayed Price · Currency is KRW 340,500
+13,500 (4.13%)
Jul 21, 2026, 2:40 PM KST
PharmaResearch Stock Forecast
Stock Price Forecast
According to 14 analysts polled by S&P Global, PharmaResearch stock has a consensus rating of "Buy" and an average price target of ₩489,071. The average 1-year stock price forecast is 43.63% higher than the current stock price, while the lowest is ₩330,000 (-3.08%) and the highest is ₩647,000 (+90.01%).
Price Target: ₩489,071 (+43.63%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for PharmaResearch stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 7 | 7 | 7 | 8 | 8 |
| Buy | 6 | 6 | 6 | 6 | 5 | 5 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 13 | 14 | 14 | 14 | 14 | 14 |
Financial Forecast
Revenue This Year
667.31B
from 536.29B
Increased by 24.43%
Revenue Next Year
806.54B
from 667.31B
Increased by 20.86%
EPS This Year
19.12K
from 14.93K
Increased by 28.06%
EPS Next Year
22.90K
from 19.12K
Increased by 19.76%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is KRW.